Summary
AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows potent anti-inflammatory and pain relieving effects. It carries out research to discover, validate, screen and optimize new disease-modifying drugs to target novel cellular pathways and suppress inflammat
Read More
- List of Tables
- AnaMar AB, Pharmaceuticals & Healthcare, Key Facts 1
- AnaMar AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
- AnaMar AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
- AnaMar AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
- AnaMar AB, Deals By Therapy Area, 2011 to YTD 2017 8
- AnaMar AB, Medical Devices Deals, 2011 to YTD 2017 9
- AnaMar AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
- AnaMar Raises U
Read More
- Table of Contents
- Table of Contents 2
- List of Tables 3
- List of Figures 4
- AnaMar AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
- AnaMar AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
- AnaMar AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
- AnaMar AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
- AnaMar AB, Medical Devices Deals, 2011 to YTD 2017 9
- AnaMar AB, Pharmaceuticals & Healthcare, Deals Summary,
Read More